Quinn Eastman @qeastman.bsky.social

More than a third of folks discontinue GLP-1 agonists after a year, according to insurance data -- half for people w/ obesity but without T2D www.ncbi.nlm.nih.gov/pmc/articles...

0 replies 0 reposts 1 likes